Finance

Lists
506690:BOM
Unichem Laboratories Ltd
502,00 INR
-1,64%
(-8,35) 1D
19-окт., 13:49:27 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 506690...
Open
501,00 INR
High
515,00 INR
Low
501,00 INR
Mkt. cap
35,52 млд
Avg. vol.
12,49 миң
Volume
742,00
P/E ratio
11,62
52-wk high
685,95 INR
52-wk low
280,00 INR
EPS
43,22 INR
Shares outstanding
70,38 млн
No. of employees
3 миң
Open
501,00 INR
High
515,00 INR
Low
501,00 INR
Mkt. cap
35,52 млд
Avg. vol.
12,49 миң
Volume
742,00
P/E ratio
11,62
52-wk high
685,95 INR
52-wk low
280,00 INR
EPS
43,22 INR
Shares outstanding
70,38 млн
No. of employees
3 миң
News stories
From web sources and news partners
Profile
Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe. Wikipedia
About Unichem Laboratories Ltd
CEO-
Employees2,78 миң
Founded1944
HeadquartersМамбай, Махараштра, Индия
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
5,79 млд
5,21 млд
5,75 млд
6,33 млд
Cost of goods sold
2,70 млд
2,37 млд
3,41 млд
2,89 млд
Cost of revenue
2,70 млд
2,37 млд
3,41 млд
2,89 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,00 млд
992,70 млн
1,05 млд
1,03 млд
Operating expense
2,74 млд
2,71 млд
2,10 млд
3,04 млд
Total operating expenses
5,44 млд
5,08 млд
5,50 млд
5,93 млд
Operating income
347,10 млн
135,30 млн
246,30 млн
400,00 млн
Other non operating income
209,70 млн
118,00 млн
-389,10 млн
156,10 млн
EBT including unusual items
-108,20 млн
2,93 млд
187,90 млн
489,90 млн
EBT excluding unusual items
474,40 млн
179,10 млн
271,70 млн
489,90 млн
Income tax expense
10,70 млн
291,40 млн
78,80 млн
75,20 млн
Effective tax rate
-9,89%
9,93%
41,94%
15,35%
Other operating expenses
1,42 млд
1,40 млд
743,50 млн
1,71 млд
Net income
-118,90 млн
2,64 млд
109,10 млн
414,70 млн
Net profit margin
-2,05%
50,71%
1,90%
6,56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
53,00 млн
-
Interest expense
-82,40 млн
-74,20 млн
-92,80 млн
-66,20 млн
Net interest expenses
-82,40 млн
-74,20 млн
-39,80 млн
-66,20 млн
Depreciation and amortization charges
314,70 млн
312,50 млн
306,10 млн
299,40 млн
EBITDA
663,40 млн
428,72 млн
541,10 млн
694,80 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору